8

CVE-2024-10476: becton dickinson & co bd bactec™ blood culture system Use of Default Credentials

CVSS: 8.0v3.1HighDeferred
Published 17-12-2024Last modified 17-12-2024

Vulnerability summary

CVE-2024-10476 is a high (CVSS 8.0) Use of Default Credentials vulnerability in becton dickinson & co bd bactec™ blood culture system. EPSS estimates a 0.24% chance of exploitation in the next 30 days, higher than 13.7% of scored vulnerabilities.

Overall risk
32/100
0100
Medium · default modelHow is this calculated?
CVSS score
8.0/10
010
High · v3.1 (CVE.org)
EPSS score
0.24%
0%100%
Low · 0.00 pp in 30 days
KEVNot listedIn no KEV catalog
RansomwareNone recordedNo known use recorded
Public exploits0No public exploits recorded

Timeline

  1. 17-12-2024
    PublishedVulnerability first disclosed.
  2. 17-12-2024
    Last modifiedVulnerability information updated.

Description

Default credentials are used in the above listed BD Diagnostic Solutions products. If exploited, threat actors may be able to access, modify or delete data, including sensitive information such as protected health information (PHI) and personally identifiable information (PII). Exploitation of this vulnerability may allow an attacker to shut down or otherwise impact the availability of the system. Note: BD Synapsys™ Informatics Solution is only in scope of this vulnerability when installed on a NUC server. BD Synapsys™ Informatics Solution installed on a customer-provided virtual machine or on the BD Kiestra™ SCU hardware is not in scope.

CVSS metrics

2 scores · 2 sources · 1 version

EPSS trend

Probability

0.24%

Chance of exploitation in the next 30 days

Percentile

14%

Versus all other CVEs

30-day change

0.00 pp

From 0.24% on 22-09-2026

22-09-202622-10-2026
EPSS score
0.24%

Known exploited

Compare KEV catalogs

Not in any of the 3 tracked catalogs.

Public exploits

0 found

No public exploits indexed.

Weaknesses

CWE · root cause

Affected systems

1 vendor · 6 products

References

1 links